285 related articles for article (PubMed ID: 28055016)
1. Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
Ye TH; Yang FF; Zhu YX; Li YL; Lei Q; Song XJ; Xia Y; Xiong Y; Zhang LD; Wang NY; Zhao LF; Gou HF; Xie YM; Yang SY; Yu LT; Yang L; Wei YQ
Cell Death Dis; 2017 Jan; 8(1):e2534. PubMed ID: 28055016
[TBL] [Abstract][Full Text] [Related]
2. Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model.
Yang F; Hu M; Lei Q; Xia Y; Zhu Y; Song X; Li Y; Jie H; Liu C; Xiong Y; Zuo Z; Zeng A; Li Y; Yu L; Shen G; Wang D; Xie Y; Ye T; Wei Y
Cell Death Dis; 2015 Mar; 6(3):e1701. PubMed ID: 25811798
[TBL] [Abstract][Full Text] [Related]
3. Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.
Zhu Y; Ye T; Yu X; Lei Q; Yang F; Xia Y; Song X; Liu L; Deng H; Gao T; Peng C; Zuo W; Xiong Y; Zhang L; Wang N; Zhao L; Xie Y; Yu L; Wei Y
Sci Rep; 2016 Feb; 6():20253. PubMed ID: 26830149
[TBL] [Abstract][Full Text] [Related]
4. Natural product pectolinarigenin exhibits potent anti-metastatic activity in colorectal carcinoma cells in vitro and in vivo.
Gan C; Li Y; Yu Y; Yu X; Liu H; Zhang Q; Yin W; Yu L; Ye T
Bioorg Med Chem; 2019 Nov; 27(21):115089. PubMed ID: 31540827
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway.
Zhu Y; Zuo W; Chen L; Bian S; Jing J; Gan C; Wu X; Liu H; Su X; Hu W; Guo Y; Wang Y; Ye T
Biochem Pharmacol; 2019 Nov; 169():113610. PubMed ID: 31465777
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
[TBL] [Abstract][Full Text] [Related]
7. Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway.
Yang L; Yao Y; Bai Y; Zheng D; Zhou F; Chen L; Hu W; Xiang Y; Zhao H; Liu Z; Wang L; Huang X; Zhao C
Phytomedicine; 2021 Jan; 80():153366. PubMed ID: 33080566
[TBL] [Abstract][Full Text] [Related]
8. Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma.
Luo Y; Zeng A; Fang A; Song L; Fan C; Zeng C; Ye T; Chen H; Tu C; Xie Y
Invest New Drugs; 2019 Oct; 37(5):1006-1013. PubMed ID: 30680584
[TBL] [Abstract][Full Text] [Related]
9. Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma.
Zhao T; Jia H; Cheng Q; Xiao Y; Li M; Ren W; Li C; Feng Y; Feng Z; Wang H; Zheng J
Oncol Rep; 2017 Jun; 37(6):3405-3414. PubMed ID: 28498414
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB
Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932
[TBL] [Abstract][Full Text] [Related]
11. LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis.
Wang H; Liu Z; Guan L; Li J; Chen S; Yu W; Lai M
Pharmacol Res; 2020 Mar; 153():104661. PubMed ID: 31982491
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use.
Jia H; Cui J; Jia X; Zhao J; Feng Y; Zhao P; Zang D; Yu J; Zhao T; Wang H; Xu K
Mol Med Rep; 2017 Dec; 16(6):9480-9486. PubMed ID: 29152660
[TBL] [Abstract][Full Text] [Related]
13. Nifuroxazide Mitigates Angiogenesis in Ehlrich's Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling.
El-Sherbiny M; El-Sayed RM; Helal MA; Ibrahiem AT; Elmahdi HS; Eladl MA; Bilay SE; Alshahrani AM; Tawfik MK; Hamed ZE; Mohamed AO; Zaitone SA
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833950
[TBL] [Abstract][Full Text] [Related]
14. Pro-Nifuroxazide Self-Assembly Leads to Triggerable Nanomedicine for Anti-cancer Therapy.
Misra SK; Wu Z; Ostadhossein F; Ye M; Boateng K; Schulten K; Tajkhorshid E; Pan D
ACS Appl Mater Interfaces; 2019 May; 11(20):18074-18089. PubMed ID: 31013055
[TBL] [Abstract][Full Text] [Related]
15. The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation.
Hu F; Li G; Huang C; Hou Z; Yang X; Luo X; Feng Y; Wang G; Hu J; Cao Z
Cell Death Dis; 2020 May; 11(5):304. PubMed ID: 32358527
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Li H; Rokavec M; Jiang L; Horst D; Hermeking H
Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
18. Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling.
Fu Q; Jiang Y; Zhang D; Liu X; Guo J; Zhao J
Mol Cell Biochem; 2016 Jul; 418(1-2):189-98. PubMed ID: 27344168
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Nifuroxazide on Proliferation, Migration, and Invasion of Thyroid Papillary Carcinoma Cells].
Hu Y; Liang LB; Zhang Q; Lan F; Lin K; He H; Li SQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):48-54. PubMed ID: 31037904
[TBL] [Abstract][Full Text] [Related]
20. Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway.
Liu X; Ji Q; Ye N; Sui H; Zhou L; Zhu H; Fan Z; Cai J; Li Q
PLoS One; 2015; 10(5):e0123478. PubMed ID: 25954974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
